Amanote Research
Register
Sign In
Discovery of Clinical Candidate (1R,4r)4-((R)2-((S)6-Fluoro5Himidazo[5,1a]isoindol-5-Yl)-1-Hydroxyethyl)cyclohexan-1-Ol (Navoximod) a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1
doi 10.1021/acs.jmedchem.9b00662.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Indoleamine 2,3-Dioxygenase 1 (IDO1)
Science-Business eXchange
(1r*,2r*)-1-(7-Bromo-3-Methoxynaphthalen-2-Yl)-4-(Dimethylamino)-2-(Naphthalen-1-Yl)-1-Phenylbutan-2-Ol
Acta Crystallographica Section E Structure Reports Online
(2s,4r)-2-[(1r)-1-(4-Bromophenyl)-2-Nitroethyl]-4-Ethylcyclohexanone
Acta Crystallographica Section E Structure Reports Online
Mapping the Binding Trajectory of a Suicide Inhibitor in Human Indoleamine 2,3 Dioxygenase 1
Biophysical Journal
Biophysics
Phase Ia Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) in Patients With Recurrent Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry
MedChemComm
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Pharmaceutical Science
Drug Discovery
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered With PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
(R,s)-Benzyl 5-(1-Hydroxyethyl)-1h-Pyrrole-2-Carboxylate
MolBank
Biochemistry
Organic Chemistry
Theoretical Chemistry
Physical
Cyclohexane-1-Spiro-2′-Imidazolidine-5′-Spiro-1′′-Cyclohexan-4′-One
Acta Crystallographica Section E Structure Reports Online
